stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Rocket Pharmaceuticals IncRCKT
$2.110.00%0.00

Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc stock is traded at $2.11, with a volume of 2,491,534. It is up 0.00% in the last 24 hours and down -3.21% over the past month. Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.
Previous Close:
$2.11
Open:
$2.09
24h Volume:
2,491,534
Relative Volume:
1.51
Market Cap:
$235.60M
Revenue:
-
Net Income/Loss:
-$209.38M
P/E Ratio:
-
EPS:
-$1.88
Net Cash Flow:
-$179.81M
1W Performance:
-14.92%
1M Performance:
-3.21%
6M Performance:
-31.27%
1Y Performance:
-28.23%
1-Day Range:
$2.06$2.22
1-Week Range:
$2.03$2.37
52-Week Range:
$2.03$5.45

Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile

Name
Rocket Pharmaceuticals Inc
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY, USA
Employee
202
Next Earnings Date
-
Latest SEC Filings
SEC
RCKT's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data

Similar to RCKT